Results 11 to 20 of about 176,903 (205)

Pneumocystis jirovecii Pneumonia [PDF]

open access: yesInfectious Disease Clinics of North America, 2010
Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus ...
Catherinot, Emilie   +5 more
core   +5 more sources

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study [PDF]

open access: yesBMC Infectious Diseases, 2009
Background In patients with chronic respiratory disease, Pneumocystis jirovecii (P. jirovecii) colonization is observed, and may influence disease progression and systemic inflammation.
Shimizu Yasuo   +6 more
doaj   +3 more sources

Pneumocystis jirovecii colonization in chronic pulmonary disease

open access: yesParasite, 2011
Pneumocystis jirovecii causes pneumonia in immunosuppressed individuals. However, it has been reported the detection of low levels of Pneumocystis DNA in patients without signs and symptoms of pneumonia, which likely represents colonization.
Gutiérrez S.   +5 more
doaj   +3 more sources

Axenic Long-Term Cultivation of Pneumocystis jirovecii

open access: yesJournal of Fungi, 2023
Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P.
Diana Riebold   +9 more
doaj   +2 more sources

Successful long-term treatment of persistent pulmonary air leak in pneumocystis jirovecii pneumonia by unidirectional endobronchial valves [PDF]

open access: yesRespiratory Medicine Case Reports, 2018
Spontaneous pneumothorax is a rare complication of pneumocystis jirovecii pneumonia. We report a patient with pneumocystis jirovecii pneumonia and therapy-refractory, right-sided pneumothorax due to persistent air leak (PAL) despite prolonged chest tube ...
Stefanie Bader   +4 more
doaj   +2 more sources

Increasing Pneumocystis Pneumonia, England, UK, 2000–2010 [PDF]

open access: yesEmerging Infectious Diseases, 2013
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000–2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Rishma Maini   +6 more
doaj   +2 more sources

Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia

open access: yesJournal of Infection in Developing Countries, 2010
Introduction: Pneumocystis jirovecii dihydropteroate synthase (DHPS) gene mutations' (55th and 57th codon) association with prior sulfa prophylaxis failure has been reported from both developed and developing countries.
Anuj Kumar Tyagi   +9 more
doaj   +2 more sources

Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations

open access: yesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2015
Pneumocystis jirovecii infection causes fulminant interstitial pneumonia ( Pneumocystis pneumonia, PCP) in patients with rheumatoid arthritis (RA) who are receiving biological and/or nonbiological antirheumatic drugs.
Shunsuke Mori, Mineharu Sugimoto
doaj   +2 more sources

Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report

open access: yesMedical Mycology Case Reports, 2018
The highest risk of opportunistic infections is from 1 to 6 months post-transplant. We report a rare case of Pneumocystis jirovecii pneumonia in a renal transplant recipient only on maintenance immunosuppression eleven years after transplant without ...
Prithiv Prasad   +2 more
doaj   +2 more sources

Pneumocystis jirovecii Pneumonia Following Initiation of 15 mg Prednisone Daily

open access: yesAnnals of Internal Medicine: Clinical Cases
A 74-year-old man with chronic obstructive pulmonary disease presented with acute dyspnea and rapidly progressed to hypoxic respiratory failure requiring high levels of noninvasive mechanical ventilation.
Matthew Anderson   +1 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy